Login / Signup

Impact of Acute Dopamine Replacement on Cognitive Function in Parkinson's Disease.

Joseph SeemillerChristopher MorrowJared Thomas HinkleKate PerepezkoVidyulata KamathGregory M PontoneKelly A Mills
Published in: Movement disorders clinical practice (2024)
Symptomatic medication differentially affects performance on two cognitive tests in PD. After acute treatment, core Stroop measures improved, Stroop interference was unchanged, and SDMT performance worsened, likely reflecting complex changes in processing speed and executive function related to acute treatment. When considering motor symptom therapies in PD, an individual's cognitive demands and expectations, especially regarding executive function, should be considered.
Keyphrases
  • liver failure
  • respiratory failure
  • healthcare
  • emergency department
  • metabolic syndrome
  • intensive care unit
  • combination therapy
  • uric acid
  • hepatitis b virus
  • adverse drug
  • patient reported